Acorn Will Present CorCap Clinical Trial Update At ACC Meeting
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular expects to complete enrollment for a 300-patient, randomized trial of its CorCap cardiac support device for heart failure by July
You may also be interested in...
Cardiologist-Friendly VAD Is In Demand; Manufacturers Advised To Start Small
The ventricular assist device market will expand only if manufacturers appeal to general cardiologists with simpler, less invasive systems, surgeons said at the TCT 2004 conference in Washington, D.C
Cardiologist-Friendly VAD Is In Demand; Manufacturers Advised To Start Small
The ventricular assist device market will expand only if manufacturers appeal to general cardiologists with simpler, less invasive systems, surgeons said at the TCT 2004 conference in Washington, D.C
Early-Stage Device Firms Challenge CV Big Five With Alternatives, Adjuncts
Small companies at the research stage are asking investors to support cardiovascular technology projects that would fill treatment gaps left open by surgical interventions and large firms' stent technologies